{"id":45659,"date":"2022-06-29T19:02:00","date_gmt":"2022-06-29T17:02:00","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/"},"modified":"2022-06-29T19:02:00","modified_gmt":"2022-06-29T17:02:00","slug":"europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/","title":{"rendered":"Europe Fabry Disease Market and Competitive Landscape &#8211; 2021 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5415776\/europe-fabry-disease-market-and-competitive?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=pm7vzq&amp;utm_campaign=1720757+-+Europe+Fabry+Disease+Market+and+Competitive+Landscape+-+2021&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Europe Fabry Disease Market and Competitive Landscape &#8211; 2021&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis research provides comprehensive insights into Fabry Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Fabry Disease market size and drug sales. It also provides insights into Fabry Disease epidemiology and late-stage pipeline.\n<\/p>\n<p>\nThis research covers the following &#8211; Fabry Disease treatment options, Fabry Disease late-stage clinical trials pipeline, Fabry Disease prevalence by countries, Fabry Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).\n<\/p>\n<p>\n<strong>Research Scope:<\/strong>\n<\/p>\n<ul>\n<li>\nCountries: Germany, France, Italy, Spain, UK, Europe\n<\/li>\n<li>\nFabry Disease pipeline: Find out drugs in clinical trials for the treatment of Fabry Disease by development phase 3, phase 2, by pharmacological class and company\n<\/li>\n<li>\nFabry Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Fabry Disease by countries\n<\/li>\n<li>\nFabry Disease drugs: Identify key drugs marketed and prescribed for Fabry Disease in the US, including trade name, molecule name, and company\n<\/li>\n<li>\nFabry Disease drugs sales: Find out the sales value for Fabry Disease drugs by countries\n<\/li>\n<li>\nFabry Disease market valuations: Find out the market size for Fabry Disease drugs in 2020 by countries. Find out how the market advanced from 2018 and forecast to 2026\n<\/li>\n<li>\nFabry Disease drugs market share: Find out the market shares for key drugs by countries\n<\/li>\n<\/ul>\n<p>\n<strong>Benefits of this Research:<\/strong>\n<\/p>\n<ul>\n<li>\nEvaluate commercial market opportunities for Fabry Disease drugs\n<\/li>\n<li>\nSynthesize insights for business development &amp; licensing\n<\/li>\n<li>\nTrack market size, competitor drug sales, market shares in Fabry Disease market\n<\/li>\n<li>\nDevelop in-depth knowledge of competition and markets\n<\/li>\n<li>\nAnalyze Fabry Disease drug sales data to update your brand planning trackers\n<\/li>\n<li>\nDevelop tactics and strategies to take advantage of opportunities in the market\n<\/li>\n<li>\nTrack Market Events and Trends and analyze key events in Fabry Disease market\n<\/li>\n<li>\nDevelop forecast models, healthcare frameworks, or economic models\n<\/li>\n<li>\nAnswer key business questions; supports decision making in R&amp;D to long term marketing strategies\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5415776\/europe-fabry-disease-market-and-competitive?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=pm7vzq&amp;utm_campaign=1720757+-+Europe+Fabry+Disease+Market+and+Competitive+Landscape+-+2021&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/4sz5hd<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x70;&#114;e&#x73;&#115;&#x40;&#114;e&#x73;&#101;&#x61;&#x72;c&#x68;&#97;n&#x64;&#109;&#x61;&#114;k&#x65;&#116;&#x73;&#46;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;r&#x65;s&#x73;&#64;&#x72;&#101;s&#x65;a&#x72;&#99;&#x68;&#97;&#x6e;&#100;m&#x61;r&#x6b;&#101;&#x74;&#115;&#x2e;&#x63;o&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Europe Fabry Disease Market and Competitive Landscape &#8211; 2021&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This research provides comprehensive insights into Fabry Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Fabry Disease market size and drug sales. It also provides insights &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45659","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Europe Fabry Disease Market and Competitive Landscape - 2021 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Europe Fabry Disease Market and Competitive Landscape - 2021 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Europe Fabry Disease Market and Competitive Landscape &#8211; 2021&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This research provides comprehensive insights into Fabry Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Fabry Disease market size and drug sales. It also provides insights ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-29T17:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Europe Fabry Disease Market and Competitive Landscape &#8211; 2021 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-29T17:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/\"},\"wordCount\":414,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005841\\\/en\\\/1501143\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/\",\"name\":\"Europe Fabry Disease Market and Competitive Landscape - 2021 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005841\\\/en\\\/1501143\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-29T17:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005841\\\/en\\\/1501143\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220629005841\\\/en\\\/1501143\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Europe Fabry Disease Market and Competitive Landscape &#8211; 2021 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Europe Fabry Disease Market and Competitive Landscape - 2021 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Europe Fabry Disease Market and Competitive Landscape - 2021 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Europe Fabry Disease Market and Competitive Landscape &#8211; 2021&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This research provides comprehensive insights into Fabry Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts Fabry Disease market size and drug sales. It also provides insights ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-29T17:02:00+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Europe Fabry Disease Market and Competitive Landscape &#8211; 2021 &#8211; ResearchAndMarkets.com","datePublished":"2022-06-29T17:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/"},"wordCount":414,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/","name":"Europe Fabry Disease Market and Competitive Landscape - 2021 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg","datePublished":"2022-06-29T17:02:00+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220629005841\/en\/1501143\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/europe-fabry-disease-market-and-competitive-landscape-2021-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Europe Fabry Disease Market and Competitive Landscape &#8211; 2021 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45659"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45659\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}